Irradiation Sterilization Services Market Report 2023-2032
The global irradiation sterilization services market was valued at USD 2.1 billion in 2022 and it is predicted to surpass around USD 5.73 billion by 2032 with a CAGR of 10.56% from 2023 to 2032.
Key Pointers
Report Scope of the Irradiation Sterilization Services Market
| Report Coverage | Details |
| Revenue Share of North America in 2022 | 41.25% |
| Revenue Forecast by 2032 | USD 5.73 billion |
| Growth Rate from 2023 to 2032 | CAGR of 10.56% |
| Base Year | 2022 |
| Forecast Period | 2023 to 2032 |
| Market Analysis (Terms Used) | Value (US$ Million/Billion) or (Volume/Units) |
| Companies Covered | Argon Medica Devices, Inc.; Cordis; Mermaid Medical; Terum Corporation; Scholten Surgical Instruments, Inc.; Changzhou Lookmed Medical Instrument Co., Ltd.; Fehling Instruments |
Irradiation sterilization is a process that uses ionizing radiation to eliminate microorganisms, including bacteria, viruses, fungi, and other pathogens. This process is commonly used to sterilize medical devices, pharmaceuticals, and food products. The demand for irradiation sterilization services has increased in recent years due to the growing concerns over foodborne illnesses and hospital-acquired infections.
The market is expanding as a result of factors such as the rise in hospital-acquired infections, technological developments in the use of sterilization agents & equipment in industrial facilities, and rising awareness of cleanliness in all institutions. On January 30, 2020, the World Health Organization (WHO) proclaimed the COVID-19 outbreak as an emergency of global significance in the public health domain. A total of 210 countries have been impacted by COVID-19. In healthcare settings, the equipment sterilization process has been essential for preventing the spread of COVID-19 infection.
By effectively sterilizing medical equipment, patient-to-patient pathogen transmission can be fully avoided. During the COVID-19 pandemic, more reprocessed equipment was used to sterilize or disinfect medical devices than usual, because improper decontamination of endoscopic, surgical, and reusable hemodialysis equipment could increase the probability of COVID-19 infection. To ensure proper sterilization of medical devices, there has been an increased demand for sterilization services. Therefore, the COVID-19 pandemic has positively impacted the growth of the global market.
The medical devices segment holds the largest share of the market for irradiation sterilization services. This is attributed to the increasing use of sterilized medical devices in surgeries and the rising number of hospitals and clinics. The food segment is also expected to grow at a significant rate due to the increasing demand for shelf-stable food products and the need to extend the shelf life of these items.
North America holds the largest share of the global market for irradiation sterilization services due to the presence of several medical device manufacturers and the growing demand for sterilized medical devices and food products in the region. The Asia-Pacific region is expected to expand at the highest rate during the forecast period due to the increasing number of hospitals and clinics in the region and the rising demand for sterilized food products and medical devices.
The various key players in the irradiation sterilization services industry offer a wide range of solutions to meet the sterilization needs of medical device manufacturers, pharmaceutical companies, and food producers. Companies utilize state-of-the-art technologies and adhere to strict quality control measures to ensure the highest levels of safety and efficacy.
Application Insights
The medical instruments segment held the largest share of 31.07% of the global market in 2022. Hospital-acquired infections are more common, and there are more surgeries requiring highly intensive infection prevention and control. The primary factors driving the global market include the rising geriatric population, and an increase in government awareness campaigns to assure high levels of infection prevention. Growing cases of chronic illnesses such as diabetes, cancer, heart disease, obesity, and respiratory problems are also expected to support market development over the forecast period.
Healthcare-associated infection is most likely to affect the growing elderly and pediatric populations, as well as patients in intensive care units. The demand for properly sterilized medical equipment, along with additional products, is predicted to drive market expansion. For instance, according to a March 2022 article in the Annals of Critical Care, the rising global population is predicted to result in a growth in the number of elderly patients admitted to critical care units (ICUs). This is expected to propel the demand for medical instruments and further boost the segment growth.
Product Type Insights
The gamma irradiation segment held the largest share of 45.98% of the global market in 2022. The high penetrating capability of gamma irradiation, which enables delivery of the intended radiation dose to parts of a product that may be denser, is an essential characteristic. In addition, when it comes to treating a wide range of products with different densities, gamma irradiation is secure, reliable, and extremely effective.
Gamma irradiation aids the production and distribution process by enabling final packaged products as well as the raw material demands, assuring complete sterility of the product. Products can be penetrated while sealed in their final packaging. This factor is expected to propel the market growth.
The X-ray irradiation segment is expected to grow at a lucrative rate during the forecast period. Photon radiation is used in the X-ray irradiation process for several purposes, such as sterilization, decontamination, and material modification. Regarding dense products, the X-ray technique offers exceptional penetration and is compatible with most materials. When treating products with different densities, X-ray irradiation is risk-free, dependable, and incredibly efficient. It is a feasible processing technique for various items due to its reduced exposure period and better Dose Uniformity Ratio (DUR).
Regional Insights
North America accounted for the largest share of 41.25% of the irradiation sterilization services market in 2022, because of its well-developed healthcare infrastructure, Due to factors like rising cases of hospital-acquired infections, advancements in technology in healthcare facilities, high patient admission rates, the region's strong industry player presence, increased government funding, growing public awareness of available technologies, and the high concentration of market players in the U.S., the North America region is predicted to dominate the market.
Asia Pacific is expected to grow at a lucrative rate during the forecast period. This is attributed to the increased use of sterilization technology, growth of the R&D industry, expansion of healthcare reforms, and improvements in medical device manufacturing technology in the region. Additionally, a large population base and an increase in funding from the public and private sectors for infection prevention and control both support the regional market's expansion.
The region's highest CAGR is anticipated to be gained in China and India, two economically developing nations that are regarded as significant contributors to healthcare spending. On the other hand, due to improving healthcare infrastructure, increased public awareness, and other factors, industry development in Latin America and the Middle East & Africa is still in its nascent stages.
Irradiation Sterilization Services Market Segmentations:
By Application
By Product Type
By Regional
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Irradiation Sterilization Services Market
5.1. COVID-19 Landscape: Irradiation Sterilization Services Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Irradiation Sterilization Services Market, By Application
8.1. Irradiation Sterilization Services Market, by Application, 2023-2032
8.1.1. Medical Instruments
8.1.1.1. Market Revenue and Forecast (2020-2032)
8.1.2. Drug
8.1.2.1. Market Revenue and Forecast (2020-2032)
8.1.3. Food & Laboratory
8.1.3.1. Market Revenue and Forecast (2020-2032)
8.1.4. Others
8.1.4.1. Market Revenue and Forecast (2020-2032)
Chapter 9. Global Irradiation Sterilization Services Market, By Product Type
9.1. Irradiation Sterilization Services Market, by Product Type, 2023-2032
9.1.1. Gamma Irradiation
9.1.1.1. Market Revenue and Forecast (2020-2032)
9.1.2. X-ray Irradiation
9.1.2.1. Market Revenue and Forecast (2020-2032)
9.1.3. E-beam Irradiation
9.1.3.1. Market Revenue and Forecast (2020-2032)
Chapter 10. Global Irradiation Sterilization Services Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, by Application (2020-2032)
10.1.2. Market Revenue and Forecast, by Product Type (2020-2032)
10.1.3. U.S.
10.1.3.1. Market Revenue and Forecast, by Application (2020-2032)
10.1.3.2. Market Revenue and Forecast, by Product Type (2020-2032)
10.1.4. Rest of North America
10.1.4.1. Market Revenue and Forecast, by Application (2020-2032)
10.1.4.2. Market Revenue and Forecast, by Product Type (2020-2032)
10.2. Europe
10.2.1. Market Revenue and Forecast, by Application (2020-2032)
10.2.2. Market Revenue and Forecast, by Product Type (2020-2032)
10.2.3. UK
10.2.3.1. Market Revenue and Forecast, by Application (2020-2032)
10.2.3.2. Market Revenue and Forecast, by Product Type (2020-2032)
10.2.4. Germany
10.2.4.1. Market Revenue and Forecast, by Application (2020-2032)
10.2.4.2. Market Revenue and Forecast, by Product Type (2020-2032)
10.2.5. France
10.2.5.1. Market Revenue and Forecast, by Application (2020-2032)
10.2.5.2. Market Revenue and Forecast, by Product Type (2020-2032)
10.2.6. Rest of Europe
10.2.6.1. Market Revenue and Forecast, by Application (2020-2032)
10.2.6.2. Market Revenue and Forecast, by Product Type (2020-2032)
10.3. APAC
10.3.1. Market Revenue and Forecast, by Application (2020-2032)
10.3.2. Market Revenue and Forecast, by Product Type (2020-2032)
10.3.3. India
10.3.3.1. Market Revenue and Forecast, by Application (2020-2032)
10.3.3.2. Market Revenue and Forecast, by Product Type (2020-2032)
10.3.4. China
10.3.4.1. Market Revenue and Forecast, by Application (2020-2032)
10.3.4.2. Market Revenue and Forecast, by Product Type (2020-2032)
10.3.5. Japan
10.3.5.1. Market Revenue and Forecast, by Application (2020-2032)
10.3.5.2. Market Revenue and Forecast, by Product Type (2020-2032)
10.3.6. Rest of APAC
10.3.6.1. Market Revenue and Forecast, by Application (2020-2032)
10.3.6.2. Market Revenue and Forecast, by Product Type (2020-2032)
10.4. MEA
10.4.1. Market Revenue and Forecast, by Application (2020-2032)
10.4.2. Market Revenue and Forecast, by Product Type (2020-2032)
10.4.3. GCC
10.4.3.1. Market Revenue and Forecast, by Application (2020-2032)
10.4.3.2. Market Revenue and Forecast, by Product Type (2020-2032)
10.4.4. North Africa
10.4.4.1. Market Revenue and Forecast, by Application (2020-2032)
10.4.4.2. Market Revenue and Forecast, by Product Type (2020-2032)
10.4.5. South Africa
10.4.5.1. Market Revenue and Forecast, by Application (2020-2032)
10.4.5.2. Market Revenue and Forecast, by Product Type (2020-2032)
10.4.6. Rest of MEA
10.4.6.1. Market Revenue and Forecast, by Application (2020-2032)
10.4.6.2. Market Revenue and Forecast, by Product Type (2020-2032)
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Application (2020-2032)
10.5.2. Market Revenue and Forecast, by Product Type (2020-2032)
10.5.3. Brazil
10.5.3.1. Market Revenue and Forecast, by Application (2020-2032)
10.5.3.2. Market Revenue and Forecast, by Product Type (2020-2032)
10.5.4. Rest of LATAM
10.5.4.1. Market Revenue and Forecast, by Application (2020-2032)
10.5.4.2. Market Revenue and Forecast, by Product Type (2020-2032)
Chapter 11. Company Profiles
11.1. STERIS
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Röchling Group
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Sterigenics
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Scapa Healthcare
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. LTE Scientific
11.5. Swann-Morton
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. SteriTek
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Beta-Gamma-Service
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Taisei Kako
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. China Biotech Corporation
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Ionisos
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
13.2. Glossary of Terms
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers